Reduced nitro-oxidative stress and neural cell death suggests a protective role for microglial cells in TNFα-/- mice in ischemic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 6, 2010, Pages 3291-3299

  Stevenson, Laura ^a   Matesanz, Nuria ^a   Colhoun, Liza ^a   Edgar, Kevin ^a   Devine, Adrian ^a   Gardiner, Tom A ^a   McDonald, Denise M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ARGINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; OXYGEN; PEROXYNITRITE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; 3-NITROTYROSINE; DRUG DERIVATIVE; NOS2 PROTEIN, MOUSE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOXIA; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; OXYGEN INDUCED RETINOPATHY; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINA CELL; RETINA ISCHEMIA; RETINOPATHY; UPREGULATION; WESTERN BLOTTING; WILD TYPE; ANIMAL; C57BL MOUSE; CELL COUNT; CELL DEATH; CYTOLOGY; ISCHEMIA; METABOLISM; MOUSE MUTANT; NITROSATION; PATHOLOGY; PHYSIOLOGY; RETINA BLOOD VESSEL; RETINA DISEASE; RETINA NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; ARGINASE; BLOTTING, WESTERN; CELL COUNT; CELL DEATH; CELL SURVIVAL; IN SITU NICK-END LABELING; ISCHEMIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; NITROSATION; OXIDATIVE STRESS; OXYGEN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RETINAL DISEASES; RETINAL NEURONS; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 77953260611     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4344     Document Type: Article

References (59)

1. Smith L, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35:101-111.
2. Gardiner TA, Gibson DS, de Gooyer TE, de la Cruz VF, McDonald DM, Stitt AW. Inhibition of tumor necrosis factor-a improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol. 2005;166:637-644.
3. Connor KM, SanGiovanni JP, Lofqvist C, et al. Increased dietary intake of (Ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007;13:868-873
4. Higuchi A, Ohashi K, Kihara S, Walsh K, Ouchi N. Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-a expression. Circ Res. 2009; 104:1058-1065.
5. Sennlaub F, Courtois Y, Goureau O. Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. JNeurosci. 2002;22:3987-3993
6. Spranger J, Meyer-Schwickerath R, Klein M, Schatz H, Pfeiffer A. TNF-alpha level in the vitreous body: increase in neovascular eye diseases and proliferative diabetic retinopathy (in German). Med Klin. 1995;90:134-137.
7. Armstrong D, Ueda T, Ueda T, et al. Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-a, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis. 1998;2:93-104.
8. Kociok N, Radetzky S, Krohne TU, Gavranic C, Joussen AM. Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice. Invest Ophthalmol Vis Sci. 2006;47:5057-5065.
9. Woo CH, Eom YW, Yoo MH, et al. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem. 2000;275:32357-32362.
10. Chiarini A, Dal Pra I, Gottardo R, Bortolotti F, Whitfield JF, Armato U. BH4 (tetrahydrobiopterin)-dependent activation, but not the expression, of inducible NOS (nitric oxide synthase)-2 in proinflammatory cytokine-stimulated, cultured normal human astrocytes is mediated by MEK-ERK kinases. J Cell Biochem. 2005;94: 731-743.
11. Huang A, Zhang YY, Chen K, Hatakeyama K, Keaney JF. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-K B and Stat1/Stat3. Circ Res. 2005;96:164-171.
12. Goureau O, Hicks D, Courtois Y, De Kozak Y. Induction and regulation of nitric oxide synthase in retinal Muller glial cells. J Neurochem. 1994;63:310-317.
13. Yoshida S, Yoshida A, Ishibashi T. Induction of IL-8, MCP-1, and bFGF by TNF-a in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefes Arch Clin Exp Ophthalmol. 2004;242:409-413
14. Kashiwagi K, Iizuka Y, Mochizuki S, et al. Differences in nitric oxide production: a comparison of retinal ganglion cells and retinal glial cells cultured under hypoxic conditions. Brain Res Mol Brain Res. 2003;112:126-134.
15. Ilg RC, Davies MH, Powers MR. Altered retinal neovascularization in TNF receptor deficient mice. Curr Eye Res. 2005;30:1003-1013
16. Sennlaub F, Courtois Y, Goureau O. Inducible nitric oxide syn-thase mediates the change from retinal to vitreal neovasculariza-tion in ischemic retinopathy. J Clin Invest. 2001;107:717-725.
17. Majka S, McGuire PG, Das A. Regulation of matrix metalloprotein-ase expression by tumor necrosis factor in a murine model of retinal neovascularization. Invest Ophthalmol Vis Sci. 2002;43: 260-266.
18. Goureau O, Regnier-Ricard F, Courtois Y. Requirement for nitric oxide in retinal neuronal cell death induced by activated Müller glial cells. J Neurochem. 1999;72:2506-2515.
19. Zheng L, Du Y, Miller C, et al. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with strep-tozotocin-induced diabetes. Diabetologia. 2007;50:1987-1996.
20. Checchin D, Sennlaub F, Levavasseur E, Leduc M, Chemtob S. Potential role of microglia in retinal blood vessel formation. Invest Ophthalmol Vis Sci. 2006;47:3595-3602.
21. Ritter MR, Banin E, Moreno SK, Aguilar EA, Dorrell MI, Friedlander M. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest. 2006;116:3266-3276.
22. Körner H, Cook M, Riminton DS, et al. Distinct roles for lympho-toxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol. 1997;27:2600-2609.
23. Possel H, Noack H, Augustin W, Keilhoff G, Wolf G. 2,7-Dihydrodi-chlorofluorescein diacetate as a fluorescent marker for peroxyni-trite formation. FEBS Lett. 1997;416:175-178.
24. El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai N-T, Caldwell RB, Liou GI. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol. 2006; 168:235-244.
25. Guzik TJ, West N, Pillai R, Taggart D, Channon KM. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension. 2002;39:1088-1094.
26. Al-Shabrawey M, Bartoli M, El-Remessy AB, et al. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic reti-nopathy. Am J Pathol. 2005;167:599-607.
27. Sawa T, Akaike T, Maeda H. Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase. J Biol Chem. 2000;275:32467-32474.
28. Gow AJ DD, Malcolm S, Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett. 1996;385:63-66.
29. McDonald D, Alp N, Channon K. Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics. 2004;14:831-839.
30. Johann AM, Barra V, Kuhn AM, Weigert A, von Knethen A, Brune B. Apoptotic cells induce arginase II in macrophages, thereby attenuating NO production. FASEB J. 2007;21:2704-2712.
31. Mander P, Borutaite V, Moncada S, Brown GC. Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neu-ronal death. J Neurosci Res. 2005;79:208-215.
32. Li J, Baud O, Vartanian T, Volpe JJ, Rosenberg PA. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci USA. 2005;102:9936-9941.
33. Yang LP, Zhu XA, Tso MO. A possible mechanism of microglia-photoreceptor crosstalk. Mol Vis. 2007;13:2048-2057.
34. Egensperger R, Maslim J, Bisti S, Holländer H, Stone J. Fate of DNA from retinal cells dying during development: uptake by microglia and macroglia (Müller cells). Brain Res Dev Brain Res. 1996;97: 1-8.
35. Zeng Hy, Zhu X, Zhang C, Yang LP, Wu LM, Tso MOM. Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest Ophthalmol Vis Sci. 2005;46:2992-2999.
36. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol. 2007;81:1345-1351.
37. Sasahara M, Otani A, Oishi A, et al. Activation of bone marrow-derived microglia promotes photoreceptor survival in inherited retinal degeneration. Am J Pathol. 2008;172:1693-1703.
38. Joly S, Francke M, Ulbricht E, et al. Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. Am J Pathol. 2009;174:2310-2323.
39. Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP, Henson PM. Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem. 2006;281:38376-38384.
40. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998;15:890-898.
41. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature. 1997;27: 350-351.
42. El-Remessy AB, Al-Shabrawey M, Platt DH, et al. Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. Am J Pathol. 2007; 21:2528-2539
43. Goureau O, Amiot F, Dautry F, Courtois Y. Control of nitric oxide production by endogenous TNF-a in mouse retinal pigmented epithelial and Muller glial cells. Biochem Biophys Res Commun. 1997;240:132-135.
44. Romero MJ, Platt DH, Tawfik HE, et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res. 2008;102:95-102.
45. El-Gayar S, Thuring-Nahler H, Pfeilschifter J, Rollinghoff M, Bogdan C. Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J Immunol. 2003;171:4561-4568.
46. Lee J, Ryu H, Ferrante RJ, Morris SM, Rattan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci USA. 2003;100:4843-4848.
47. Platt DH, Bartoli M, El-Remessy AB, et al. Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3. Free Radic Biol Med. 2005 39:1353-1361.
48. Arbiser JL, Petros J, Klafter R, et al. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci U S A. 2002;99:715-720.
49. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res. 2006;71:226-235.
50. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
51. Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003; 161:1163-1177.
52. Pierce E, Avery R, Foley E, Aiello L, Smith L. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995;92:905-909.
53. Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E. The role of vascular endothelial growth factor and astrocyte degeneration in the pathogenesis of retinopathy of prematurity. Invest Ophthal-mol Vis Sci. 1996;37:290-299.
54. Gu X, Samuel S, El-shabrawey M, et al. Effects of sustained hyper-oxia on revascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2002;43:496-502.
55. Downie LE, Pianta JM, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL. AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy. Glia. 2008; 56:1076-1090.
56. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest. 2002;109:41-50.
57. Golpon HA, Fadok VA, Taraseviciene-Stewart L, et al. Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J. 2004;18:1716-1718.
58. Elkabes S, DiCicco-Bloom EM, Black IB. Brain microglia/macro-phages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci. 1996;16:2508-2521.
59. Nakajima K, Microglia SK. Neuroprotective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord. 2004;4:65-84.